Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Wutyi, Aung"'
Autor:
Jenell S, Coleman, Clarissa P, Diniz, Edward J, Fuchs, Mark A, Marzinke, Wutyi, Aung, Rahul P, Bakshi, Homayoon, Farzadegan, Jay H, Bream, Tricia L, Nilles, Sherry, Hudson, Namandjé N, Bumpus, George J, Schwartz, Michael A, Rosenblum, James F, Rooney, Craig W, Hendrix
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 92:89-96
Depot medroxyprogesterone acetate (DMPA) is a widely used contraceptive method. HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil fumarate (F/TDF) is highly effective in reducing HIV acquisition in women. We sought to determine
Autor:
Jessica Radzio, Wutyi Aung, Angela Holder, Amy Martin, Elizabeth Sweeney, James Mitchell, Shanon Bachman, Chou-Pong Pau, Walid Heneine, J Gerardo García-Lerma
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e50632 (2012)
BACKGROUND: Daily pre-exposure prophylaxis (PrEP) with Truvada (a combination of emtricitabine (FTC) and tenofovir (TFV) disoproxil fumarate (TDF)) is a novel HIV prevention strategy recently found to prevent HIV transmission in men who have sex with
Externí odkaz:
https://doaj.org/article/e07061d6d2a84259a2631455746a2313
Autor:
Namandjé N. Bumpus, Mark A. Marzinke, Edward J. Fuchs, Craig W. Hendrix, Tonia Poteat, Todd T. Brown, Rahul P. Bakshi, Jennifer C. Breakey, Wutyi Aung, Eugenie Shieh, Allyson N. Hamlin
Publikováno v:
Journal of the International AIDS Society
Introduction Oral HIV Pre‐Exposure Prophylaxis (PrEP) with tenofovir (TFV) disoproxil fumarate (TDF)/emtricitabine (FTC) is highly effective. Transgender women (TGW) have increased HIV risk, but have been underrepresented in trials. For TGW on oest
Autor:
Ellen N Kersh, Debra R Adams, Ae S Youngpairoj, Wei Luo, Qi Zheng, Mian-er Cong, Wutyi Aung, James Mitchell, Ron Otten, R Michael Hendry, Walid Heneine, Janet McNicholl, J Gerardo Garcia-Lerma
Publikováno v:
PLoS ONE, Vol 6, Iss 4, p e19295 (2011)
Pre-exposure prophylaxis (PrEP) with anti-viral drugs is currently in clinical trials for the prevention of HIV infection. Induction of adaptive immune responses to virus exposures during anti-viral drug administration, i.e., a "chemo-vaccination" ef
Externí odkaz:
https://doaj.org/article/f8e49bc1628044578f1bd30ab42ea873
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 98:407-416
Topical microbicidal agents are being actively pursued as a modality to prevent HIV viral transmission during sexual intercourse. Quantification of antiretroviral agents in specimen sources where antiviral activity is elicited is critical, and drug m
Autor:
Craig W. Hendrix, Hans M. L. Spiegel, Christine Radebaugh, Edward J. Fuchs, Lisa C. Rohan, Wutyi Aung, Mark A. Marzinke, Jennifer A. Robinson, Rahul P. Bakshi, Jenell S. Coleman
Publikováno v:
AIDS research and human retroviruses. 33(4)
While preexposure prophylaxis with oral tenofovir/emtricitabine reduces HIV acquisition rates, poor adherence to and acceptability of vaginal gels and the potential for evolving drug resistance have led to development of vaginal film formulations and
Autor:
Maya Nadison, Rebecca A. Aslakson, Erica Koegler, Jeffrey Duong, Peter J. Pronovost, Wutyi Aung, Jessica Peters, Kerry Shannon, Lauren Redstone, Selena Jingjing An
Publikováno v:
Critical Care Medicine. 40:1-328
Publikováno v:
The journal of applied laboratory medicine. 1(2)
Background Medroxyprogesterone acetate (MPA) is a common contraceptive agent taken both orally and as a subcutaneous or intramuscular injection. Current LC-MS/MS methods for MPA quantification require large sample volumes and low-throughput analytica
Autor:
Wei Luo, Susan Kuklenyik, William A. Lee, Ellen N. Kersh, Chou Pong Pau, Walid Heneine, Adrian S. Ray, James F. Rooney, Qi Zheng, Wutyi Aung, Angela Holder, J. Gerardo García-Lerma, James Mitchell, Amy Martin, Ae S. Youngpairoj, Carol Yen Chin Lin, Debra L. Hanson, Mian Er Cong
Publikováno v:
Journal of Virology. 85:6610-6617
Preexposure prophylaxis (PrEP) with antiretroviral drugs is a novel human immunodeficiency virus (HIV) prevention strategy. It is generally thought that high systemic and mucosal drug levels are sufficient for protection. We investigated whether GS73
Autor:
Mark A. Marzinke, Jenell S. Coleman, Craig W. Hendrix, Rahul P. Bakshi, Wutyi Aung, Jennifer A. Robinson, Hans M. L. Spiegel, Edward J. Fuchs
Publikováno v:
Contraception. 93(4)
Objective To determine the feasibility of using quantitative changes in vaginal permeability to small molecules as a measure of candidate microbicide toxicity. Study design Controlled, open-labeled, prospective study. Seven healthy women received a s